Find out how these two forms differ and learn if either form has health benefits and if it is safe
Clinical trials show that phentermine-topiramate produces meaningful weight loss within the first 3 months of treatment
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
Saxenda (liraglutide 3.0 mg) is a GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with obesity or overweight with weight-related comorbidities
A practical rotation schedule: abdomen during weeks 1-4, upper thigh during weeks 5-8, upper arm during weeks 9-12, then back to abdomen for maintenance
Eli Lillys triple agonist, retatrutide, demonstrated an average weight loss of 16.8% in a Phase 3 trial for the treatment of type 2 diabetes, the company announced today